Crohn's disease after surgery: Changes in post‐operative management strategies over time and their impact on long‐term re‐operation rate—A retrospective multicentre real‐world study

Annalisa Aratari,Maria Lia Scribano,Daniela Pugliese,Valentina Baccolini,Fabiola De Biasio,Serena Verna,Chiara Morretta,Stefano Festa,Alessandro Armuzzi,Claudio Papi
DOI: https://doi.org/10.1111/apt.18001
IF: 9.524
2024-04-15
Alimentary Pharmacology & Therapeutics
Abstract:Summary Background Few data are available addressing the impact of post‐operative management of Crohn's disease (CD) on long‐term clinical course. Aim To assess the evolution of post‐operative management strategies over the last 40 years and their impact on the re‐operation rate of CD. Methods We included 657 patients with CD who had undergone their first radical ileo‐caecal resection between 1980 and 2020. Three cohorts were defined according to year of surgery: cohort 1 (1980–1998; n = 198), cohort 2 (1999–2009; n = 218) and cohort 3 (2010–2020; n = 241). We estimated exposure to immunomodulators and anti‐TNFα agents after surgery and rates of re‐operation using Kaplan–Meier survival analyses. We used Cox proportional hazards regression to assess the association of clinical variables with time to re‐operation. Results Immunosuppressants, (IMMs) and anti‐TNFα exposure within 5 years after surgery increased significantly from cohort 1 to cohort 2 and cohort 3 (IMMs: 1.6%, 38.2% and 28.0%, respectively, p
pharmacology & pharmacy,gastroenterology & hepatology
What problem does this paper attempt to address?